CRINETICS PHARMACEUTIC
59.81
07-November-24 14:59:58
15 minutes delayed
Stocks
+0.65
+1.10%
Today's range
58.66 - 60.17
ISIN
N/A
Source
NASDAQ
-
08 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
02 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 15:05:00 By Nasdaq GlobeNewswire
-
19 Mar 2024 05:00:00 By Nasdaq GlobeNewswire
-
12 Mar 2024 15:05:00 By Nasdaq GlobeNewswire
-
11 Mar 2024 15:05:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
28 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
14 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
12 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
10 Jan 2024 15:33:42 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
18 Dec 2023 15:05:00 By Nasdaq GlobeNewswire
-
11 Dec 2023 15:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Upcoming Investor Conferences
20 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
-
10 Nov 2023 16:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
07 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Oct 2023 16:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023
20 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
12 Sep 2023 21:26:42 By Nasdaq GlobeNewswire